Advertisement

Drugs & Therapy Perspectives

, Volume 23, Issue 2, pp 14–18 | Cite as

Reproductive health issues demand careful consideration of antiepileptic drug (AED) therapy in women with epilepsy

Disease Management

References

  1. 1.
    Tettenborn B. Management of epilepsy in women of childbearing age: practical recommendations. CNS Drugs 2006; 20(5): 373–87PubMedCrossRefGoogle Scholar
  2. 2.
    Jacoby A, Baker GA, Steen N, et al. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. community study. Epilepsia 1996; 37(2): 148–61PubMedCrossRefGoogle Scholar
  3. 3.
    Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2 052 922 and age-specific fertility rates of women with epilepsy. Lancet 1998; 352: 1970–3PubMedCrossRefGoogle Scholar
  4. 4.
    Crawford P, Hudson S. Understanding the information needs of women with epilepsy at different lifestages: results of the ‘Ideal World’ survey. Seizure 2003; 12: 502–7PubMedCrossRefGoogle Scholar
  5. 5.
    Jallon P, Picard F. Bodyweight gain and anticonvulsants: a comparative review. Drug Saf 2001; 24: 969–78PubMedCrossRefGoogle Scholar
  6. 6.
    Bauer J, Isojärvi JI, Herzog AG, et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 2002; 73: 121–5PubMedCrossRefGoogle Scholar
  7. 7.
    Quality Standards Committee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Neurology 1998; 51: 944–8CrossRefGoogle Scholar
  8. 8.
    Crawford P, Appleton R, Betts T, et al. Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group. Seizure 1999; 8: 201–17PubMedCrossRefGoogle Scholar
  9. 9.
    NHS, National Institute for Clinical Excellence. Newer drugs for epilepsy in adults. Technology appraisal 76: March 2004 [online]. Available from URL: http://www.nice.org.uk [Accessed 13 Sep 2006]
  10. 10.
    Delgado-Escueta AV, Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 1992; 42Suppl. 5: 149–60PubMedGoogle Scholar
  11. 11.
    Yerby MS, Kaplan P and Tran T. Risks and management of pregnancy in women with epilepsy. Cleve Clin J Med 2004; 71(2): S25–37PubMedCrossRefGoogle Scholar
  12. 12.
    Perucca E. Birth defects after prenatal exposure to antiepileptic drugs. Lancet Neurol 2005; 4: 781–6PubMedCrossRefGoogle Scholar
  13. 13.
    Craig JJ, Russell A, Parsons L, et al. The UK Epilepsy and Pregnancy Register: update of results 1996–2003. Epilepsia 2004; 45Suppl. 7: 229Google Scholar
  14. 14.
    Holmes LB, Wyszynski DF. North American Antiepileptic Drug Pregnancy Registry. Epilepsia 2004; 45: 1465PubMedCrossRefGoogle Scholar
  15. 15.
    Vajda F, Lander C, O’Brien T, et al. Australian Pregnancy Registry of women taking antiepileptic drugs. Epilepsia 2004; 45: 1466PubMedCrossRefGoogle Scholar
  16. 16.
    Cunnington MC. The International Lamotrigine Pregnancy Registry update for The Epilepsy Foundation. Epilepsia 2004; 45: 1468PubMedCrossRefGoogle Scholar
  17. 17.
    Hernandez-Diaz S, Werler MM, Walker AM, et al. Folie acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343: 1608–14PubMedCrossRefGoogle Scholar
  18. 18.
    Yerby MS. Management issues for women with epilepsy: neural tube defects and folic acid supplementation. Neurology 2003; 61Suppl. 2: S23–6PubMedCrossRefGoogle Scholar
  19. 19.
    Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol 1993; 168: 884–48PubMedGoogle Scholar
  20. 20.
    Bruno MK, Harden CL. Epilepsy in pregnant women. Curr Treat Options Neurol 2002; 4: 31–40PubMedCrossRefGoogle Scholar
  21. 21.
    Kaaja E, Kaaja R, Matila R, et al. Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 2002; 58: 549–53PubMedCrossRefGoogle Scholar
  22. 22.
    Choulika S, Grabowski E, Holmes LB. Is antenatal vitamin K prophylaxis needed for pregnant women taking anticonvulsants? Am J Obstet Gynecol 2004; 190: 882–3PubMedCrossRefGoogle Scholar
  23. 23.
    Adab N, Jacoby A, Smith D, et al. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001; 70: 15–21PubMedCrossRefGoogle Scholar
  24. 24.
    Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004; 75: 1575–83PubMedCrossRefGoogle Scholar
  25. 25.
    Hagg S, Spigset O. Anticonvulsant use during lactation. Drug Saf 2000; 22: 425–40PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2007

Personalised recommendations